Heron Therapeutics, Inc.

Back to All Transactions

Heron Therapeutics, Inc.
For more information regarding this transaction contact:
  • Dave McDonald Investment Banking 612.326.1268

Lake Street is pleased to announce it served as a co-managing underwriter for Heron Therapeutics, Inc. (Nasdaq:HRTX) in its underwritten public offering of 6,000,000 shares of common stock at an offering price of $26.00 per share. Gross proceeds totaled $156 million.

About Heron Therapeutics, Inc.

Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class medicines that address major unmet medical needs. Heron is developing novel, patient-focused solutions that apply its innovative science and technologies to already-approved pharmacological agents for patients suffering from cancer or pain.

Contact

Mike Townley
Head of Investment Banking

612.326.1313

Email Mike
 

Dave McDonald
Head of Life Science Investment Banking

612.326.1268

Email Dave

 

Tim Klein

Investment Banking

612.260.6173

Email Tim

 

Rob Martin

Investment Banking

612.260.5850

Email Rob

 

Steve Rickman

Investment Banking

612.326.1985

Email Steve